Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC RVX-297 50mg | 1044871-04-6 | 423.50 | C24H29N3O4 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY11450450MG

Encompass_Preferred

RVX-297 is a potent, orally active BD2-selective BET bromodomain inhibitor used in preclinical research to study inflammation and autoimmune disease mechanisms. It preferentially binds BD2 domains of BET proteins and suppresses inflammatory gene expression.

  • BD2-selective BET bromodomain inhibitor for mechanistic studies.
  • Orally active in preclinical models of inflammation and autoimmunity.
  • Potent activity: BRD2(BD2) IC50 = 0.08 μM, BRD3(BD2) = 0.05 μM, BRD4(BD2) = 0.02 μM.
  • High purity (95.0%) suitable for in vitro and in vivo research.
  • Stable solid: powder storage recommended at low temperatures for long-term stability.

Catalog No. 50-003-08018


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.